Delivery Order SPE2DB20D1100-SPE2DB24FB2T9

Award Date 4/15/24
Potential Completion Date 5/6/24
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) has awarded a delivery order contract valued at $12,595.00 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is for the supply of 400 mg vials of the medication BENLYSTA. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of BENLYSTA 400 MG VIALS. The award, valued at $1,259.50, was made by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,515.15 firm fixed-price delivery order is for the supply of 400 mg vials of the drug Benlysta, with a completion date of January 6, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of Benlysta 200 mg/ml syringes to the Defense Logistics Agency (DLA). The $2,790.98 delivery order is a firm-fixed price contract with a completion date of July 17, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a large Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with the DLA Troop Support Medical to provide a wide range of pharmaceutical products and...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of BENLYSTA 400 MG VIALS to the Defense Logistics Agency (DLA). The contract, valued at $11,213.60, is a firm fixed price delivery order with a period of performance through July 11, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $6,554.80 firm-fixed-price contract is for the supply of 400 mg vials of the pharmaceutical drug Benlysta. This order is a part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a comprehensive range of medical...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product Benlysta 200 mg/mL syringe to the U.S. Defense Department. The $5,581.96 firm-fixed-price delivery order has a completion date of July 11, 2024 and was awarded on June 18, 2024. The award is not associated with a set-aside program. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,519.00 firm-fixed price contract is for the provision of BENLYSTA 400 mg vials, a pharmaceutical product. The contract has a completion date of June 11, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp, a subsidiary of one of the largest pharmaceutical distribution companies in the world, holds a significant...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, is a delivery order valued at $13,854.50 for the supply of 400 mg vials of the medication BENLYSTA. The award was issued by the Defense Logistics Agency (DLA), a defense agency within the Department of Defense. The contract does not have a set-aside designation and is a firm fixed price delivery order with an ultimate completion date of April 29, 2024. Amerisourcebergen Drug Corp is...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product Benlysta. The contract has a firm fixed price of $2,793.03 and a completion date of May 28, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FB2T9
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $13,854.50 firm fixed price delivery order is for the supply of 400 mg vials of the prescription medication Benlysta.

Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This specific delivery order is not designated as a set-aside contract.

Generated 7/15/24, 6:53 PM